These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9723445

  • 21. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
    Stepkowski SM, Chen H, Daloze P, Kahan BD.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):507-8. PubMed ID: 1990602
    [No Abstract] [Full Text] [Related]

  • 24. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract] [Full Text] [Related]

  • 25. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC, Tian L, Wang M, Wang ME, Stepkowski SM, Kahan BD.
    Transplantation; 1997 Nov 27; 64(10):1407-14. PubMed ID: 9392303
    [Abstract] [Full Text] [Related]

  • 26. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
    Zhang J, Song Z, Wijkström M, Bari S, Sundberg B, Nava S, Groth CG, Korsgren O, Wennberg L.
    Transplant Proc; 2000 Aug 27; 32(5):1017. PubMed ID: 10936327
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 27; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation.
    Antoniou EA, Drayson M, Howie AJ, McMaster P, D'Silva M.
    Transplant Proc; 1998 Jun 27; 30(4):1042-3. PubMed ID: 9636420
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
    Troncoso P, Stepkowski SM, Wang ME, Qu X, Chueh SC, Clark J, Kahan BD.
    Transplantation; 1999 Jan 15; 67(1):145-51. PubMed ID: 9921811
    [Abstract] [Full Text] [Related]

  • 33. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation.
    Xu M, Antoniou EA, Afford SC, Suzuki S, Pirenne J, McMaster P, D'Silva M.
    Transplant Proc; 1997 Nov 15; 29(7):2964-6. PubMed ID: 9365631
    [No Abstract] [Full Text] [Related]

  • 34. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transpl Immunol; 2000 Jun 15; 8(2):115-24. PubMed ID: 11005317
    [Abstract] [Full Text] [Related]

  • 35. Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts.
    Wasowska B, Hancock WW, Onodera K, Korom S, Stadlbauer TH, Zheng XX, Strom TB, Kupiec-Weglinski JW.
    Transplant Proc; 1997 Jun 15; 29(1-2):333. PubMed ID: 9123026
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K, Hoshino Y, Ohtsuki M, Kataoka H, Maeda Y, Matsuyuki H, Sugahara K, Kiuchi M, Hirose R, Adachi K.
    Transplant Proc; 2005 Jun 15; 37(1):102-6. PubMed ID: 15808561
    [Abstract] [Full Text] [Related]

  • 40. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
    Stepkowski SM, Tian L, Napoli KL, Ghobrial R, Wang ME, Chou TC, Kahan BD.
    Clin Exp Immunol; 1997 Apr 15; 108(1):63-8. PubMed ID: 9097913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.